Imagine a camera that can see things twice as clearly as the best medical scanners today. By using quantum light and AI to block out noise, it creates a crystal-clear 3D map of the eye. It's like upgrading from a standard TV to 4K for doctors looking at the retina.
Current medical 3D imaging for eyes has hit a physical wall at 1 µm resolution. This prevents doctors from seeing finer details necessary for early disease detection and suffers from environmental noise.
A Quantum OCT system featuring an ultra-stable comb source, AI-controlled spatial light modulators, and specialized single-photon avalanche diode (SPAD) arrays, supported by the first-ever QOCT software.
If you are a medical device manufacturer dealing with the 1 µm axial resolution limit of current scanners — this project developed a Quantum OCT system that provides a x2 improvement in resolution. This allows for much earlier and more precise detection of retinal diseases.
If you are an optical sensor developer dealing with environmental noise and signal interference — this project developed AI-based OAM control and ultra-low noise comb sources. This ensures higher image quality and better edge definition for chiral objects.
If you are a software firm dealing with the lack of quantum-ready processing tools — this project developed the first ever QOCT software. This enables the analysis of high-dimensional OAM data for superior 3D imaging.
Based on available project data, the specific commercial price of the system is not mentioned; however, the project received an EU contribution of EUR 6,435,635 for development.
The project is currently in the research and integration phase, aiming to deliver the highest resolution OCT system ever built, but it has not yet reached mass industrial scale.
Based on available project data, specific licensing terms are not disclosed, but the consortium includes 4 industry partners and 3 SMEs who are developing the core hardware and software.
The project is extending world-leading classical OCT software to create QOCT software, suggesting a path toward integration with existing digital imaging workflows.
The project period runs from 2022-11-01 to 2026-07-31, indicating that final results and validations will be completed by mid-2026.
The consortium is well-balanced for commercialization, featuring 11 partners across 7 countries. With a 36% industry ratio (including 3 SMEs), there is a strong bridge between the 5 universities and 2 research institutes and the actual market. The presence of NKT Photonics as coordinator ensures that the project is led by a company with world-leading supercontinuum source expertise.
Contact NKT Photonics AS in Denmark for licensing and partnership inquiries.
Contact us to connect with the SEQUOIA consortium for early adoption of quantum imaging.
